Binge Eating Disorder Medication: Options & Safety Guidelines | Rittenhouse Psychiatric Associates

Medication for binge-eating disorder 

Binge-eating disorder (or BED) is a common, treatable medical condition marked by recurring episodes of consuming unusually large amounts of food, feeling out of control during the episodes, and experiencing distress regarding the binge eating. Someone with binge-eating disorder may eat quickly even when they are not hungry, or eat to the point of feeling sick or uncomfortably full. They may eat alone because of shame about the amount of food they are eating or may feel disgusted with themselves afterwards. Binge episodes are not related to a lack of control or willpower, and recovery is possible. Medication can be one useful tool in recovery, but medication is most helpful as part of a broader treatment plan that includes therapy, dietary support, and medical care. 

This guide explains the medication options used for BED, including the one medication specifically approved by the U.S. Food and Drug Administration (FDA), as well as other medications sometimes prescribed. This blog will review current medication options and how they work, potential side effects and safety issues, the current treatment guidelines, and how to have a productive conversation with your doctor. This article is educational and is not a substitute for individualized medical advice from your own care team.

How medication fits into binge-eating disorder treatment

Medication management is generally one part of a multidisciplinary approach to BED rather than a stand-alone solution. Current guidelines recommend cognitive behavioral therapy (CBT) or interpersonal psychotherapy (IPT) as first-line treatments for BED. Nutrition management from a dietitian familiar with eating disorders can also help establish more consistent eating patterns and address any restrictive eating or other factors that can contribute to binge eating.

A clinician may discuss medication management when symptoms are moderate to severe, when psychotherapy alone has not provided enough improvement, or when there are other co-occurring conditions such as depression or attention-deficit/hyperactivity disorder (ADHD). The goal of medication management is to reduce binge episodes and improve day-to-day functioning, not simply to change body weight.

Treatment for BED is individualized and may change over time depending on response to treatment, side effects, access to care, and specific circumstances. It is important to seek providers who are experienced in treating eating disorders. These clinicians will focus on your relationship with food and your overall well-being rather than on weight loss alone.

Are there any new FDA-approved medications for binge-eating disorder?

At the time of writing this blog, lisdexamfetamine (brand name: Vyvanse) remains the only medication approved by the FDA for moderate-to-severe BED in adults. 

FDA approval is significant. It means a medication has gone through clinical trials for a specific condition, that the agency has reviewed the evidence for benefit and safety, and that the drug can be marketed and prescribed for that specific use. The other medicines discussed later in this guide are used “off-label,” meaning they are FDA approved for a different condition but not approved specifically for BED. 

Despite active research into other compounds, there are currently no new medications approved to treat BED. If you hear about a “new BED medication,” ask your prescriber or check current FDA information and clinical guidelines before assuming it is approved for BED.

Lisdexamfetamine (Vyvanse): the only FDA-approved medication for BED

Lisdexamfetamine is a central nervous system stimulant that was approved in 2007 for ADHD. Later, in 2015, it was approved for moderate-to-severe BED in adults. In clinical trials, it reduced the number of binge-eating days per week compared with placebo and also lowered obsessive or compulsive thoughts about eating. Lisdexamfetamine is not approved or intended as a weight-loss drug.

Lisdexamfetamine increases the activity of dopamine and norepinephrine, which are chemical messengers in the brain. These chemical changes are thought to alter the reward pathways, decreasing the powerful urge to eat and reducing impulsive and compulsive eating. 

Common side effects include dry mouth, insomnia, decreased appetite, constipation, and feeling jittery or anxious. As a stimulant, it can also raise blood pressure and heart rate. Lisdexamfetamine is a schedule II controlled substance and carries an FDA warning about the risk of misuse, abuse, and dependence. 

Given these risks, psychiatrists should carefully review pertinent medical history, which includes screening for heart disease, anxiety, sleep disorders, substance use and bipolar disorder. Family history of cardiac concerns should also be taken into account before prescribing lisdexamfetamine. Doctors will monitor for any changes in vital signs, sleep and mood. They will also monitor for any signs of misuse and may stop the medication if problematic side effects emerge.   

Potential use of off-label medications for binge-eating disorder

“Off-label” prescribing means that a doctor uses a medication approved for one condition to treat a different condition when there is reasonable evidence and clinical rationale. This is legal, common, and can be clinically appropriate for BED, particularly when there are individual concerns regarding the use of lisdexamfetamine, the only FDA-approved drug. The categories below are described to inform and not to recommend any specific drug. Please be sure to talk to your psychiatrist about the treatment plan that’s right for you.

Selective Serotonin Reuptake Inhibitors (SSRIs) such as fluoxetine, sertraline or escitalopram may modestly reduce binge eating frequency and are often used when someone has depression or anxiety that also needs treatment. However, the evidence does not establish any one particular antidepressant as preferable for treating BED. 

Topiramate, an anti-seizure medicine, may reduce binge episodes and appetite, but sedation, cognitive side effects (such as word-finding difficulties or mental “fogginess”), tingling sensations, and other adverse effects limit its use. Because topiramate can also affect appetite and weight, clinicians should carefully consider its use in the context of an individual’s eating disorder recovery. It should not be used for weight loss alone.

The quality of evidence varies a great deal from drug to drug, and some options have been tested in only a few small studies. For these reasons, off-label medication for BED should be started and monitored closely by a psychiatrist who understands eating disorders, and who can watch for the ways a weight-focused medication might unintentionally work against recovery.

Weight loss and GLP-1 medications when you have BED

GLP-1 receptor agonists, such as semaglutide (brand name: Ozempic), are FDA approved for conditions such as type 2 diabetes, cardiovascular risk reduction and weight management. They are not FDA approved for BED. Because GLP-1 medications can reduce appetite and increase feelings of fullness, they may seem appealing to someone struggling with binge eating. The research remains limited, however, and there are insufficient large, long-term randomized trials to establish GLP-1 medications as standard treatment for BED.

For someone with an eating disorder, appetite suppression is not the same as recovery. While we live in a weight-centric, diet-culture society, being in a larger body does not mean someone is unhealthy. GLP-1 medications may do harm by perpetuating a focus on thinness. And depending on the individual, strong appetite suppression or a focus on weight can contribute to restrictive eating, increased preoccupation with food or body size, body-image distress, or unhealthy binge/restrict cycles. Emerging literature emphasizes that GLP-1 treatment should be considered very carefully in people with current or past disordered eating.

If you are already taking a GLP-1 medication, this does not mean you have done anything wrong or need to stop it on your own. Instead, it is recommended that you:

• Tell the prescriber about your BED diagnosis or binge-eating symptoms.

• Discuss whether appetite suppression is interfering with adequate, regular nutrition.
• Watch for increasing restrictive eating, food anxiety, compulsive weight checking, or worsening body-image distress.
• Coordinate care between the medication prescriber, psychiatrist, therapist, and dietitian when appropriate.
• Do not start, stop, or change a GLP-1 medication without medical guidance.

Safety, side effects, and when to consider a medication for BED

Every medication used to treat BED has a different safety profile, but common concerns include changes in appetite, sleep disturbance, gastrointestinal symptoms, anxiety or other mood changes, and interactions with other medications. Because of an individual’s medical history, current symptoms, or other concurrent treatments, a medication that is appropriate for one person may not be appropriate for another. 

Certain medical conditions require additional caution with medication use. Before taking stimulant medications such as lisdexamfetamine, people with heart disease, high blood pressure, or other cardiovascular concerns may need specific evaluation including an electrocardiogram (ECG or EKG). Pregnancy may change the discussion regarding risks and benefits of several medications, including stimulants and topiramate. A complete medical history will help a psychiatrist identify these issues before treatment begins.

Mental health history is also an important factor. A past or current substance use disorder is particularly important when considering a controlled substance such as a stimulant. Clinicians may also need to account for significant anxiety, mood instability, bipolar disorder, or other psychiatric conditions when selecting and monitoring medication. These factors do not automatically preclude the use of medication; they just mean the treatment plan should be individualized and monitored carefully.

For all of these reasons, it is necessary to schedule regular follow-up appointments with your psychiatrist to ensure the safe use of medications. Psychiatrists may monitor blood pressure and heart rate, blood work, sleep, mood, gastrointestinal symptoms, substance use, medication interactions, and changes in binge-eating frequency. Any side effects should be discussed with your psychiatrist during these appointments. However, any severe or rapidly worsening symptoms warrant prompt contact with your psychiatrist. If you experience chest pain, fainting, a very fast or irregular heartbeat, severe agitation or confusion, high fever with muscle rigidity, new thoughts of self-harm – or any reaction that feels severe or frightening – seek medical evaluation immediately. Never start, stop, or change a BED medication without guidance from a qualified medical professional.

Practical BED medication guidelines

There is no single medication plan that works for everyone with BED. Instead, clinicians often use a step-by-step process that includes symptom assessment, shared decision-making, and ongoing monitoring:

1. Start with an evaluation. Assess the severity and pattern of binge eating, review medical and psychiatric history, identify co-occurring conditions and establish the diagnosis.

1. Discuss treatment options. Ask about evidence-based psychotherapy, nutrition management, medication, or a combination of these options. Talk openly about concerns regarding appetite, weight, side effects, controlled substances, and/or previous medication experiences.

1. Agree on a treatment plan. If medication is selected, get clarity about the initial dose, expected benefits, potential side effects, and when a psychiatrist might adjust or discontinue the medication.

1. Monitor progress. Track meaningful changes such as binge frequency, urges, mood, sleep and any side effects. Depending on the medication and clinical situation, benefits may be assessed over several weeks to a few months.

1. Adjust as needed. If the medication is not beneficial or causes problematic side effects, the psychiatrist will consider dose changes, switching to another medication, discontinuation, or even a different treatment approach.

Medication is most useful when it is integrated with evidence-based therapy rather than relied upon as a stand-alone solution. As discussed in the beginning of this blog, CBT or IPT are first-line treatments for BED. For adults with BED who have not responded adequately to psychotherapy alone, the American Psychiatric Association suggests they be treated with either an antidepressant medication (such as an SSRI) or lisdexamfetamine. 

When setting goals, it is important to consider measures not related to weight. Useful goals may include fewer binge episodes, less distress around eating, greater flexibility with food, improved sleep or mood, better concentration, more social engagement, and a stronger sense of control without restrictive eating. A good treatment plan will support improved day-to-day functioning rather than focus on the numbers on a scale.

Questions to ask your doctor about binge-eating disorder medication

To prepare for a medical appointment, it can be helpful to think about your questions ahead of time. The questions below are designed to open a collaborative conversation with your doctor, and you can adapt them to your situation.

To understand if medication is appropriate and what to expect, you might ask your physician:

• Given my symptoms, medical history, and mental health history, is a medication like lisdexamfetamine or an SSRI safe and appropriate for me?
• What benefits might I realistically expect, how long until we know if the medication is working, and what would “success” look like for me?
• What side effects are most likely, which ones are serious, and how will we monitor them over time?
• Are there heart, blood pressure, pregnancy, or substance-use considerations I should know about with this medication?

To make sure a medication fits into your treatment plan, consider asking your physician:

• How will this medication work alongside therapy and nutrition management? Can you help connect me to professionals who provide those services?
• Could this medication interact with my other prescriptions, over-the-counter medicines, or supplements?
• Is this medication being prescribed off-label for BED, and what does that mean for me?
• What is the plan if the first medication we try doesn’t help or isn’t tolerable? What would we try next?
• Will my insurance cover this, and are there generic or lower-cost options?

If you are considering medication for BED, a psychiatrist who specializes in eating disorders can help you weigh the potential risks and benefits while keeping your broader mental health, nutrition, and relationship with food at the center of care. The clinicians at Rittenhouse Psychiatric Services are ready to help guide your recovery and provide the care you deserve. 

If you are interested in seeking an evaluation for an eating disorder, contact our team to set up an appointment.